For the Culture By The Culture
A German biotech is pushing a cannabis pill called VER 01 and calling it a breakthrough for pain relief. Beneath the pharmaceutical polish is a deeper story about control, money, and culture. Pot Culture Magazine asks if Vertanical’s lab born weed is progress or just another corporate grab for the plant the people built.
In Part Two of our exclusive interview with former High Times Magazine Editor-in-Chief Chris Simunek, the conversation turns raw. From outlaw growers and underground legends to lost friends and a culture gutted by greed, Simunek reflects on the rise and fall of cannabis journalism. This is not nostalgia. This is what the movement lost when legalization cashed in.
Massachusetts health officials report a surge in pediatric cannabis ER visits, but the real culprit is the unregulated hemp gray market. Candy-lookalike edibles and weak enforcement fuel fear while licensed operators take the blame. Pot Culture Magazine cuts through the panic to expose how prohibitionist loopholes and corporate spin create the danger.
Colorado regulators just banned Midnight Drops after reports linked the cannabis sleep aid to liver injuries. Nuka Enterprises and affiliates were fined $400,000 and booted from the state, but loopholes may allow their return. This is not about the plant. It is about corporate shortcuts, weak oversight, and the way scandals weaponize prohibitionist narratives against cannabis culture.
For decades, junk science has fueled cannabis prohibition, from bogus chromosome scares to today’s clickbait about weed causing diabetes. Despite billions in tax revenue and no overdose deaths, scare studies dominate headlines while real-world data proves otherwise. This piece exposes how research funding, media bias, and political agendas keep cannabis criminalized against all evidence.
California lawmakers finally moved to ease the crushing cannabis excise tax, but after years of bleeding growers dry, is it reform or just window dressing? Pot Culture Magazine digs into the numbers, the damage, and the politics behind the belated rollback.
